Invitae Corp

SAN FRANCISCO, CA · Founded 2010 · CIK 0001501134 · Medtech · Acquired

Genetic testing platform for DNA sequencing and variant analysis

invitae.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$203M
8 Form D · Apr 2020
78 months since last filing
Contracts
$3.7M
31 awards · Health and Human S, Defense, Veterans Affairs
#147 of 4531 in medtech
Patents
40
17 granted · 23 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,644,999
Private capital raisedForm D · SEC$2,299,999
Private capital raisedForm D · SEC$29,557,113
Federal contractDepartment of Health and Human Services · Invitae CORPORATION:1273948 [17-004286] Igf::ot::igf Laboratory Testing Services.$2,850
Private capital raisedForm D · SEC$6,007,102
Private capital raisedForm D · SEC$16,083,491
Private capital raisedForm D · SEC$73,500,000
Federal contractDepartment of Veterans Affairs · Igf::ot::igf - Germline Genetic Testing$148,100
Federal contractDepartment of Veterans Affairs · Igf::ot::igf - Germline Genetic Testing$2,850
Federal contractDepartment of Defense · Boosted Exome, Trio, Lab Tests,$4,500
Federal contractDepartment of Defense · Igf::ot::igf Lab Tests: Invitae: Boosted Exome Trio$9,000
Federal contractDepartment of Veterans Affairs · Igf::ot::igf - Germline Genetic Testing$3,400
Federal contractDepartment of Veterans Affairs · Genetic Testing Igf::ot::igf$57,475
Federal contractDepartment of Defense · Genetic Testing Lab Tests$47,500
Federal contract· 1 of 2 same dayDepartment of Veterans Affairs · Igf::ot::igf Gentetic Test$74,100
Federal contract· 2 of 2 same dayDepartment of Veterans Affairs · Igf::ot::igf - Germline Genetic Testing$298,475
Federal contractDepartment of Veterans Affairs · Genetic Testing Referral Laboratory$345,060
Federal contractDepartment of Veterans Affairs · INVI$126,425
Federal contractDepartment of Veterans Affairs · Emergency Germ Line Testing$302,110
Private capital raised· 1 of 2 same dayForm D · SEC$19,679,155
Private capital raised· 2 of 2 same dayForm D · SEC$52,373,418
Federal contractDepartment of Veterans Affairs · Genetic Testing Services$32,650
Federal contract· 1 of 2 same dayDepartment of Veterans Affairs · Contract Award Invitae Genetics Reference Laboratory Testing$169,695
Federal contract· 2 of 2 same dayDepartment of Veterans Affairs · Genetic Testing For The Slcvamc, Genomic Medicine$390,900
Federal contractDepartment of Veterans Affairs · Genetic Testing For The Slcvamc, Genomic Medicine$641,360
Federal contractDepartment of Veterans Affairs · Next Generation Testing$4,750
Federal contractDepartment of Veterans Affairs · Genetic Testing Referral$118,174
Federal contractDepartment of Veterans Affairs · Contract Award Invitae Genetics Reference Laboratory Testing$119,675
Federal contractDepartment of Veterans Affairs · Laboratory Service, San Francisco Health Care Services (R-11365)$14,725
Federal contractDepartment of Veterans Affairs · Reference Lab Testing$95,119
Federal contractDepartment of Veterans Affairs · Genetics Testing$159,600
Federal contractDepartment of Veterans Affairs · Genetic Laboratory Testing$1,020
Federal contractDepartment of Veterans Affairs · Reference Lab Testing$122,350
Federal contractDepartment of Health and Human Services · Clinical Testing For Nhgri Clinical Investigators$25,000
Federal contractDepartment of Veterans Affairs · Genetic Testing Kits$202,024
Federal contractDepartment of Veterans Affairs · Genetic Testing$130,500
Federal contractDepartment of Veterans Affairs · Ratification$7,900
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
144Springactive, Inc.$3.8M—
145Mattek Corporation$3.8M—
146MDxHealth$3.7M—
147Invitae Corp$3.7M$203M
148ISENSE, LLC$3.6M—
149BIOPAC SYSTEMS, INC.$3.6M—
150AI BIOSCIENCES, INC.$3.6M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Eric AguiarDirector
  • Lee BendekgeyExecutive Officer
  • Michele CargillExecutive Officer
  • Geoffrey CrouseDirector
  • Sean GeorgeDirector · Executive Officer
  • Christine GorjancDirector
  • Shelly GuyerExecutive Officer
  • Chitra NayakDirector
  • Anya SchiessDirector
  • Randal ScottDirector · Executive Officer
  • Richard TompaneExecutive Officer

Patents

USPTO · 17 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.